On September 5, 2019 KemPharm, Inc. (Nasdaq:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported that its president and chief executive officer, Travis C. Mickle, Ph.D., will present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co. being held September 8-10, 2019, at the Lotte New York Palace Hotel (Press release, KemPharm, SEP 5, 2019, http://investors.kempharm.com/news-releases/news-release-details/kempharm-present-21st-annual-global-investment-conference [SID1234539312]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of KemPharm’s presentation are as follows:

Event: 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.
Date: Monday, September 9, 2019
Time: 2:35 PM ET
Location: Lotte New York Palace Hotel, New York, NY
The presentation will be webcast and available on the Investor Relations section of the Company’s website at View Source